Revealing the Potential of Fucus vesiculosus Linnaeus for Cosmetic Purposes: Chemical Profile and Biological Activities of Commercial and Wild Samples Authors: Marina Muñoz-Quintana, Carolina Padrón-Sanz, Marina Dolbeth, Francisco Arenas, Vitor Vasconcelos, Graciliana Lopes, Maria Elisa Giuliani, Marco Malavolta Published: 2024 ABSTRACT AbstractThe natural products industry is gaining increasing interest, not only due to modern lifestyles becoming more aware of environmental and sustainability issues but also because of the loss of efficacy and undesirable side effects of synthetic ingredients. This pioneering study provides a comprehensive comparison between extracts obtained from wild and commercial samples of Fucus vesiculosus Linnaeus, highlighting their multifaceted benefits in cosmetic applications. The antiaging potential of acetone (70 and 90%) and ethanol 60% extracts from wild and commercial samples of F. vesiculosus, focusing on their application in cosmetics, was explored. The extracts were chemically characterized, their carotenoid profiles being established by HPLC, and the total phenolic content and phlorotannins by spectrophotometry. The extracts were evaluated for their antioxidant potential against the physiologic free radicals superoxide anion radical (O2•−) and nitric oxide (•NO), for their ability to inhibit the enzymes hyaluronidase and tyrosinase, and for their anti-inflammatory potential in the macrophage cell model RAW 264.7. The acetone 70% extract of wild F. vesiculosus was the richest in fucoxanthin, which accounted for more than 67% of the total pigments identified, followed by the acetone 90% extract of the same sample, where both fucoxanthin and pheophytin-a represented 40% of the total pigments. The same behavior was observed for phenolic compounds, with the ethanol 60% presenting the lowest values. A chemical correlation could be established between the chemical composition and the biological activities, with acetone extracts from the wild F. vesiculosus, richer in fucoxanthin and phlorotannins, standing out as natural ingredients with anti-aging potential. Acetone 90% can be highlighted as the most effective extraction solvent, their extracts presenting the highest radicals scavenging capacity, ability to inhibit tyrosinase to a greater extent than the commercial ingredient kojic acid, and potential to slow down the inflammatory process.Keywords: antioxidant, anti-inflammatory, fucoxanthin, tyrosinase, cosmetics 1. Introduction Cosmetics have played an important role in human culture since ancient times. Initially derived from fruits, plants, and minerals, cosmetics were mostly used for religious and ornamental purposes [1]. Nowadays, the cosmetics business is one of the most significant and rapidly expanding sectors of the global economy, with a global revenue of USD 100.49 billion [2]. The cosmetics industry is anticipated to grow even more; in fact, according to recent projections, its European market will grow at a Compounded Average Growth Rate (CAGR) of 2.6% between 2022 and 2027 [3], and its global market will grow at a CAGR of roughly 5.5% between 2021 and 2028 [4]. Based on this, the market is demanding innovative, greener, and more sustainable solutions, in addition to increasing the use of natural products, due to the growing interest of consumers, industries, organizations, and the scientific community in reducing environmental impacts [5,6]. One of the most interesting and explored cosmetic properties related to skin aging is antioxidant activity, which is related to oxidative stress, a complex process involving internal and external factors (environmental variables such as pollution and UV radiation) where reactive oxygen species (ROS) and reactive nitrogen species (RNS) play an important role [7,8,9,10]. Consequently, during the previous several years, oxidative stress research has advanced quickly, and both the scientific community and the population have become more conscious of the importance of antioxidants [11,12]. Synthetic ingredients have been employed for many years; however, they have drawbacks, such as limited absorption rates and negative side effects [13,14]. Thus, as a consequence of modern lifestyle demands and the loss of efficacy of these products, natural bioactive substances are preferred [14,15]. In this context, seaweeds appear as rich sources of natural bioactive compounds with a variety of biological actions, making them suitable as active ingredients in cosmetic formulations [14,16,17,18]. Algal extracts contain a wide range of bioactive molecules from different classes: proteins, peptides, carbohydrates, minerals, iodine, lipids (PUFAs), phenols (polyphenols, tocopherols), alkaloids, terpenes, and pigments (chlorophylls, carotenoids, and phycobilins) that make them suitable for many purposes [12,19]. Among these components, one of the most promising applications is the development of cosmeceuticals and skin-care products [14]. In fact, macroalgae cultivation has expanded to answer the growing demand for the use of seaweed extracts for cosmetic formulations for sensitive skin, among others [20]. Seaweed bioactive extracts are employed as active ingredients in skin-whitening, anti-aging, colorants, thickening/gelling agents, or moisturizers [12,21,22]. Additionally, in some regions, seaweeds are used as an alternative therapy for skin-related disorders such as psoriasis and dermatitis [23,24], making them excellent natural raw materials for cosmetics with multiple benefits for health [15,16,25,26]. Among them, brown seaweeds occupy a prominent place for health and cosmetics due to their high antioxidant and anti-inflammatory activities, among others [27]. Particularly, some species of brown algae, such as Fucus vesiculosus Linnaeus, gained interest in recent years due to their abundance and significant commercial value as sources of natural ingredients with cosmetic and cosmeceutical applications [28,29,30]. Among the most interesting bioactive compounds of this species are pigments (chlorophylls and carotenoids) and polyphenols, more precisely phlorotannins [14]. Furthermore, the inhibitory effects of F. vesiculosus bioactive compounds on enzymes related to skin aging and the non-enzymatic glycation process were studied, proving effective against these processes and therefore demonstrating their potential to be employed as antioxidants and skin-lightening agents [31]. However, despite studies showing the high potential of the Fucus species in the cosmetics sector, it is known that the conditions in which they are collected, such as the season, can significantly influence their composition and, consequently, bioactivity [32,33]. To our knowledge, few studies have been conducted comparing the chemical composition and biological activities of wild and commercial seaweeds. Therefore, the objective of this work is to explore and compare the potential of different extracts obtained from wild and commercial F. vesiculosus for their cosmetic applications by evaluating their anti-inflammatory potential and their ability to inhibit key enzymes involved in the inflammatory process and scavenge physiologic free radicals, establishing a relationship between their chemical composition and bioactivity. 2. Results 2.1. Phytochemical Characterization 2.1.1. Pigments Profile The carotenoid and chlorophylls profile of the different extracts, obtained from wild and commercial F. vesiculosus by HPLC-PDA, revealed the presence of four carotenoids, one chlorophyll derivative, chlorophyll a, and pheophytin a in the wild samples, and three carotenoids, eight chlorophyll derivatives, and pheophytin-a in the commercial ones (Table 1). The identified compounds for wild extracts included fucoxanthin (1), a violaxanthin isomer (2), β-carotene (8), β-carotene derivative (10), and zeaxanthin (4) among the carotenoids; and chlorophyll-a (3), chlorophyll-a derivative (7), and pheophytin-a (9) among the chlorophylls. For commercial extracts, the carotenoids identified were fucoxanthin (1), zeaxanthin (4), β-carotene (8), and β-carotene derivative (10); and the chlorophylls were 9 chlorophyll derivatives (5, 6, 7, 10, 11, 12, 13, 14, 15) and pheophytin-a (9). The chromatographic profile of wild F. vesiculosus acetone 90% extract is illustrated in Figure 1. Table 1Carotenoid and chlorophylls content (µg/g DE) in extracts of commercial and wild Fucus vesiculosus obtained with different solvents, determined by HPLC-PDA 1,2.PeakCompoundRTCommercial Fucus vesiculosus (µg/g DE)Wild Fucus vesiculosus (µg/g DE)Acetone 90%Acetone 70%Ethanol 60%Acetone 90%Acetone 70%Ethanol 60%1Fucoxanthin6.2028.83 ± 1.40 d16.29 ± 1.38 d3.24 ± 0.60 d3857.02 ± 149.06 b7067.12 ± 302.7 a2046.61 ± 107.20 c2Violaxanthin isomer9.03ndndnd22.07 ± 8.64nqnq3Chlorophyll-a15.26ndndnd225.71 ± 39.86 b2820.69 ± 106.39 and4Zeaxanthin15.70nqnqndnqndnd5Chlorophyll derivative25.30365.07 ± 1.51 a60.36 ± 18.71 bndndndnd6Chlorophyll derivative26.1973.12 ± 5.00nqndndndnd7Chlorophyll derivative27.50nd73.84 ± 6.57 bndnd109.91 ± 6.79 and8β-carotene27.61107.77 ± 3.03 bndnd1120.01 ± 156.69 a14.93 ± 1.49 b5095.36 ± 14.90 a9Pheophytin-a27.85738.94 ± 24.72 c89.44 ± 14.19 dnd3911.95 ± 221.58 b482.17 ± 21.05 c,dnd10β-carotene derivative28.3022.53 ± 0.31 bndnd251.07 ± 110.78 andnd11Chlorophyll derivative28.9028.03 ± 1.14ndndndndnd12Chlorophyll derivative29.2172.774 ± 13.25ndndndndnd13Chlorophyll derivative32.39312.93 ± 13.79 a33.95 ± 2.93 bndndndnd14Chlorophyll derivative33.70284.22 ± 26.45ndndndndnd15Chlorophyll derivative34.50112.5 ± 12.96ndndndndndTotal Carotenoids159.13 ± 4.74 d16.29 ± 1.38 d3.24 ± 0.6 d5318.07 ± 329.15 b7082.05 ± 304.19 a2046.61 ± 107.2 cTotal Chlorophylls1987.58 ± 98.82 d273.70 ± 48.00 end4137.65 ± 261.44 b3412.77 ± 134.23 c5095.36 ± 14.90 a1 Values are expressed as mean ± SD of two determinations. 2 Different superscript letters in the same row denote statistical differences at p < 0.05 (ANOVA, Tukey HSD, t-test). nd: not detected. nq: not quantified. DE, dry extract. Carotenoid and chlorophylls content (µg/g DE) in extracts of commercial and wild Fucus vesiculosus obtained with different solvents, determined by HPLC-PDA 1,2. 1 Values are expressed as mean ± SD of two determinations. 2 Different superscript letters in the same row denote statistical differences at p < 0.05 (ANOVA, Tukey HSD, t-test). nd: not detected. nq: not quantified. DE, dry extract. Carotenoid and chlorophylls profile of acetone 90% extract of the wild Fucus vesiculosus. HPLC-PDA recorded at 450 nm. Fucoxanthin (1), violaxanthin isomer (2), chlorophyll-a (3), zeaxanthin (4), β-carotene (8), pheophytin-a (9), and β-carotene derivative (10). Fucoxanthin (1) was one of the main pigments quantified in all the extracts, with significant differences being observed for the extracts obtained from the wild F. vesiculosus: acetone 70% had the highest concentration (7067.12 ± 302.7 µg/g DE) followed by acetone 90% (3857.02 ± 149.06 µg/g DE) and ethanol 60% extract (2046.61 ± 107.20 µg/g DE). Regarding commercial samples, no significant differences were observed for the amount of this compound with the different extraction solvents, its concentration being much lower compared with the extracts obtained from the wild sample. For the extracts obtained from the wild sample, total carotenoid concentrations ranged between 2046.61 and 7082.05 µg/g of dry extract (DE), with acetone 70% being the richest and ethanol 60% the poorest extract. Regarding chlorophylls, their concentration ranged between 3412.77 and 5095.36 µg/g DE, with ethanol 60% extracts presenting the highest amount and acetone 70% the lowest (p < 0.05). All the extracts of the wild F. vesiculosus contained fucoxanthin (1), β-carotene (8), and pheophytin-a (9), with chlorophyll-a (3) only being present in acetonic 70% and 90% extracts. Acetone 70% extract was the richest in fucoxanthin and acetone 90% in pheophytin-a (Table 1). The extracts obtained from the commercial F. vesiculosus were significantly the poorest in all the pigments analyzed. Total carotenoids ranged from 3.24 to 159.13 µg/g DE. Chlorophylls were dominant over carotenoids, ranging between 273.70 and 1987.58 µg/g DE in acetone 70% and acetone 90% extracts, respectively (p < 0.05). All the extracts of the commercial sample contained fucoxanthin (1), this being the only pigment found in the ethanolic extract. As expected, the results showed that extracts obtained from the wild sample are richer in both carotenoids and chlorophylls, which can be explained, at least in part, by the sample processing methods, e.g., lyophilization for the wild samples versus less conservative methods with higher exposure to oxygen during the drying process of the commercial F. vesiculosus. Additionally, the time that elapsed between the collection, drying, and analysis of the commercial samples could also lead to the degradation of some metabolites and consequently affect their chemical profile. Although the amounts of carotenoids and chlorophylls were lower in the commercial sample, the high percentage of chlorophyll derivatives (5, 6, 10, 11, 12, 13, 14, 15) in acetone 90% extracts must be highlighted. Among all the samples analyzed, wild ones were richer in both chlorophylls and carotenoids. Comparing the different solvents, acetone 90% must be highlighted for its high amount of β-carotene (8), fucoxanthin (1), and pheophytin-a; acetone 70% extracts stand out for their significant amount of chlorophyll-a (3) and fucoxanthin (1). Ethanol 60% extracts were the poorest, with only the major compounds (fucoxanthin, β-carotene, and pheophytin-a) being quantified. 2.1.2. Total Phenolic Content (TPC) and Total Phlorotannin Content (TPhC) The results of TPC and TPhC are displayed in Table 2. Table 2Total phenolic content (TPC) and Total Phlorotannin Content (TPhC) (µg PhEq/mg DE) in Fucus vesiculosus extracts obtained with different solvents 1,2.SolventTPC (µg PhEq/mg DE)TPhC (µg PhEq/mg DE)CommercialWildCommercialWildAcetone 90%723.48 ± 117.06 c,d1903.83 ± 53.21 a5.42 ± 0.20 B,C15.91 ± 1.22 AAcetone 70%500.95 ± 63.85 d,e1042.75 ± 51.69 b3.02 ± 0.70 C,D2.89 ± 0.94 DEthanol 60%361.20 ± 24.32 e792.28 ± 65.37 b,cnq6.77 ± 0.86 B1 Mean ± SD of at least two independent assays. 2 Different superscript letters in the same assay denote statistical differences at p < 0.05 (ANOVA, Tukey HSD). nq: Not quantified. DE, dry extract. PhEq, phloroglucinol equivalents. Total phenolic content (TPC) and Total Phlorotannin Content (TPhC) (µg PhEq/mg DE) in Fucus vesiculosus extracts obtained with different solvents 1,2. 1 Mean ± SD of at least two independent assays. 2 Different superscript letters in the same assay denote statistical differences at p < 0.05 (ANOVA, Tukey HSD). nq: Not quantified. DE, dry extract. PhEq, phloroglucinol equivalents. Extracts from the wild F. vesiculosus presented higher TPC values compared to commercial extracts. Among them, the highest TPC was found in acetone 90%, followed by acetone 70% and ethanol 60% extracts (1903.83, 1042.75, and 792.28 µg/mg, respectively) (p < 0.05). Extracts of the commercial samples had the same pattern, with acetone 90% extract presenting the highest TPC and ethanol 60% the lowest (723.48 and 361.20 µg/mg, respectively) (p < 0.05). Regarding TPhC, the highest values were found in the acetone 90% extract of the wild sample (15.91 µg/mg), with the extracts of the commercial ones presenting lower values (5.42 µg/mg) (p < 0.05). Phlorotannins were below the limit of quantification in the ethanol 60% extracts of the commercial sample. 2.2. Antioxidant Capacity The dose-dependent O2•− scavenging activity of the extracts obtained from commercial and wild F. vesiculosus samples are displayed in Figure 2, while the IC50 values are presented in Table 3. Generally, the extracts obtained from commercial samples revealed weak O2•− scavenging ability, while those obtained from wild ones were significantly more effective. Superoxide anion radical (O2•−) scavenging activity of extracts obtained from commercial (a) and wild (b) Fucus vesiculosus samples. Values are expressed as the mean ± SD of at least three independent experiments, performed in duplicate. Table 3Half-maximal inhibitory concentration (IC50) values obtained for O2•− (mg DE/mL) and •NO (µg DE/mL) scavenging, by extracts of commercial and wild Fucus vesiculosus obtained with different solvents 1,2.SolventO2•− Scavenging IC50 (mg DE/mL)•NO Scavenging IC50 (µg DE/mL)CommercialWildCommercialWildAcetone 90%1.15 ± 0.06 b0.30 ± 0.06 a38.22 ± 9.48 B12.09 ± 2.71 AAcetone 70%1.55 ± 0.19 c0.39 ± 0.17 a58.63 ± 6.99 C29.02 ± 4.72 A,BEthanol 60%1.23 ± 0.18 b1.59 ± 0.15 c166.30 ± 15.41 D27.35 ± 7.98 A,B1 Mean ± SD of at least three independent assays. 2 Different superscript letters in the same assay denote statistical differences at p < 0.05 (ANOVA, Tukey HSD). DE, dry extract. Half-maximal inhibitory concentration (IC50) values obtained for O2•− (mg DE/mL) and •NO (µg DE/mL) scavenging, by extracts of commercial and wild Fucus vesiculosus obtained with different solvents 1,2. 1 Mean ± SD of at least three independent assays. 2 Different superscript letters in the same assay denote statistical differences at p < 0.05 (ANOVA, Tukey HSD). DE, dry extract. In wild samples, acetone 90% and acetone 70% extracts were the most effective, showing the lowest IC50 values (0.30 and 0.39 mg/mL, respectively), while in commercial samples the most effective extracts were acetone 90% and ethanol 60% (1.15 and 1.23 mg/mL, respectively). Comparing wild and commercial samples, there are significant differences in the three extraction solvents mentioned: acetone 90%, acetone 70%, and ethanol 60% (p < 0.05). A negative correlation can be established between the IC50 values obtained for O2•− scavenging, TPC (p < 0.01), and TPhC (p < 0.05), suggesting that these compounds contribute to the free radical scavenging (Table 2, Table 3 and Table 4). Moreover, there is also a negative correlation between O2•− scavenging and carotenoids, such as fucoxanthin (p < 0.01). Table 4Half-maximal inhibitory concentration (IC50) values obtained for tyrosinase (µg DE/mL) and hyaluronidase (HAase) (mg DE/mL) in the presence of different extracts obtained from commercial and wild Fucus vesiculosus 1,2.SolventTyrosinase Inhibition IC50 (µg DE/mL)HAase Inhibition IC50 (mg DE/mL)CommercialWildCommercialWildAcetone 90%4.19 ± 0.78 b1.23 ± 0.3 a0.26 ± 0.01 C,D0.05 ± 0.01 AAcetone 70%8.96 ± 2.18 c2.71 ± 0.35 a,b0.29 ± 0.05 D0.16 ± 0.01 BEthanol 60%14.76 ± 2.0 d3.64 ± 0.38 a,b0.17 ± 0.06 B,C0.26 ± 0.05 C,D1 Mean ± SD of at least three independent assays. 2 Different superscript letters in the same assay denote statistical differences at p < 0.05 (ANOVA, Tukey HSD). DE, dry extract. Half-maximal inhibitory concentration (IC50) values obtained for tyrosinase (µg DE/mL) and hyaluronidase (HAase) (mg DE/mL) in the presence of different extracts obtained from commercial and wild Fucus vesiculosus 1,2. 1 Mean ± SD of at least three independent assays. 2 Different superscript letters in the same assay denote statistical differences at p < 0.05 (ANOVA, Tukey HSD). DE, dry extract. The •NO scavenging activity of the extracts obtained from commercial and wild F. vesiculosus samples is displayed in Figure 3, while the respective IC50 values are presented in Table 3. Nitric oxide radical (•NO) scavenging activity of extracts obtained from commercial (a) and wild (b) Fucus vesiculosus samples. Values are expressed as the mean ± SD of at least three independent experiments, performed in duplicate. All the extracts analyzed presented a dose-dependent behavior. However, the extracts of the commercial F. vesiculosus revealed weaker •NO scavenging activity compared to the wild ones, which were significantly more effective in reaching lower IC50 values. The acetonic extracts were the most effective, with acetone 90% presenting the lowest IC50 for both commercial and wild samples (38.22 and 12.09 µg DE/mL, respectively; p = 0.003), closely followed by acetone 70% extracts (58.63 and 29.02 µg DE/mL, respectively; p = 0.001). Ethanolic extracts (IC50 = 166.30 and 27.35 µg DE/mL, respectively; p = 0.000) presented the weakest capacity to scavenge •NO. According to the statistical analysis, it seems that phenolic compounds play an important role in •NO scavenging, and phlorotannins play an important role in this behavior (p < 0.01). Therefore, as one of the aims of this research is to compare the antioxidant potential of the F. vesiculosus extracts by evaluating their capacity to scavenge different physiological free radicals generated in vitro, acetone 90% extract obtained from the wild F. vesiculosus can be identified as the optimal extract, with acetone 90% being the best extraction solvent for both samples. 2.3. Enzymes Inhibition 2.3.1. Tyrosinase Inhibition The tyrosinase inhibition capacities of the commercial and wild F. vesiculosus under study are displayed in Figure 4, while the IC50 values are presented in Table 4. Tyrosinase inhibition of extracts obtained from the commercial (a) and wild (b) samples of Fucus vesiculosus. Values are expressed as the mean ± SD of at least three independent experiments, performed in duplicate. Wild F. vesiculosus presented higher tyrosinase inhibitory potential compared with the commercial one. Acetone 90% extract obtained from the wild species showed the lowest IC50 value (1.23 µg/mL), followed by acetone 70% and ethanol 60% (2.71 and 3.64 µg/mL, respectively). Among the commercial samples, acetone 90% exhibited the highest tyrosinase inhibitory potential (4.19 µg DE/mL) and ethanol 60% the lowest (14.76 µg DE/mL) (p < 0.05). Considering wild and commercial samples, there are significant differences between the three extraction solvents mentioned: acetone 90% (p = 0.058), acetone 70% (p = 0.000), and ethanol 60% (p = 0.000). These values were compared with kojic acid, a known skin-lightening ingredient, with an IC50 value of 4.09 ± 0.47 µg DE/mL: acetone 90% extract of the wild sample was about three times more effective than the mentioned cosmetic ingredient. In addition, there is a significative negative correlation (p < 0.01) between the TPC, phlorotannins, and tyrosinase IC50 values, suggesting that these compounds play an important role in tyrosinase inhibition. 2.3.2. Hyaluronidase (HAase) Inhibition Extracts of the wild F. vesiculosus were able to promote the highest HAase inhibition, with acetone 90% presenting the lowest IC50 (0.05 mg DE/mL) and ethanol 60% the highest (0.26 mg DE/mL) (p < 0.05) (Table 4). Considering wild and commercial samples, there are significant differences in the three extraction solvents mentioned: acetone 90% (p = 0.000), acetone 70% (p = 0.001), and ethanol 60% (p = 0.074). The IC values obtained with the extracts were compared with that of disodium cromoglicate (DSGC), a natural inhibitor of HAase, with an IC50 value of 1.11 ± 0.030 mg DE/mL, all of them presenting greater inhibitory activity than the natural inhibitor. A negative correlation (p < 0.01) between TPC, phlorotannins, and HAase inhibition was found, which might point to these compounds as important players in the mentioned biological activity. In fact, the best results obtained with wild F. vesiculosus correspond to the extracts with the highest TPC, and phlorotannins consequently. Therefore, as one of the aims of this research is to determine the ability of F. vesiculosus extracts to inhibit key enzymes involved in the skin aging process, acetone 90% extract of wild species can be identified as the optimal extract for both tyrosinase and HAase inhibition, with acetone 90% being the best extraction solvent for both samples. 2.4. Anti-Inflammatory Potential 2.4.1. Viability Cytotoxic effects were screened in RAW 264.7 macrophages for both acetonic and ethanolic extracts of commercial and wild F. vesiculosus. For both samples, none of the extracts showed cytotoxic effects under the tested concentrations, with no significant differences compared to the control (p > 0.05) for 24 h of exposition, for which all the extracts were considered viable for further analysis (Figure 4). 2.4.2. Effect in LPS-Stimulated RAW 264.7 Cells The anti-inflammatory potential of F. vesiculosus extracts was explored in a cell system by determining their capacity to reduce •NO produced by RAW 264.7 cells under LPS stimulation. A pre-exposition to the extracts without LPS stimulation was undertaken to examine the effect of the extracts on basal •NO levels, and then discard any possible pro-inflammatory activity. The extracts alone did not affect the basal •NO levels. Cells were then pre-exposed to serial concentrations of the different extracts obtained from commercial and wild samples and then stimulated with bacterial LPS. After a 22 h stimulation period with LPS, RAW 264.7 exhibited a marked decrease in •NO levels in the culture medium, for the highest concentrations tested, without any toxicity (Figure 5). Nitric oxide production by RAW 264.7 cells in the presence of commercial and wild Fucus vesiculosus acetone 90% (a), acetone 70% (b), and ethanol 60% (c) extracts, after stimulation with lipopolysaccharide (LPS). Results are expressed as % of nitrite (NO2−) relative to the control stimulated with LPS. “Basal” represents the nitric oxide produced by RAW 264.7 cells without LPS stimulation. Results are expressed as the mean ± SD of at least three independent assays * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (ANOVA, Tukey HSD, Dunnett HSD). As can be seen in Figure 4 and Table 5, the LPS-induced production of •NO decreased in a dose-dependent way in the presence of both commercial and wild samples (12.5 to 200 µg DE/mL), resulting in a decrease in •NO production with the acetone 90% extract to 65.76 and 57.76%, for the wild and commercial F. vesiculosus samples, respectively, as compared to the LPS-stimulated control. Both samples had a similar IC25 (136.29 ± 65.41 and 88.82 ± 27.75 µg DE/mL, respectively). The acetone 70% extract of the commercial sample was close to achieving IC50 for a concentration of 200 µg/mL (50.46% •NO production; IC25 = 99.94 ± 22.60 µg DE/mL), closely followed by the acetone 70% extract of the wild sample (64.95% of •NO production; IC25 = 146.04 ± 64.17 µg DE/mL). Additionally, cells exposed to ethanolic extracts of wild and commercial samples presented •NO production of 50.97% (IC25 = 109.83 ± 12.17 µg DE/mL) and 58.57% (IC25 = 148.39 ± 50.73 µg DE/mL) for the highest concentration tested. There were no significant differences between both groups of samples (commercial vs. wild); however, differences can be observed between the different extraction solvents. It is remarkable that a higher phlorotannin content relates to a higher anti-inflammatory potential of the extracts, reaching lower IC25 values in acetone 90% extracts, followed by acetone 70% and ethanol 60%. Cell viability did not decrease in any of the concentrations tested, indicating that the extracts do not exert a cytotoxic effect. Table 5Inhibitory concentration (IC25) values (µg DE/mL) obtained for nitric oxide (•NO) production by LPS-stimulated RAW 264.7 cells in the presence of different extracts of commercial and wild Fucus vesiculosus 1.Solvent•NO Production IC25 (µg DE/mL)CommercialWildAcetone 90%88.82 ± 27.75136.29 ± 65.41Acetone 70%99.94 ± 22.60146.04 ± 64.17Ethanol 60%148.39 ± 50.73109.83 ± 12.171 Mean ± SD of at least two independent assays. DE, dry extract. Inhibitory concentration (IC25) values (µg DE/mL) obtained for nitric oxide (•NO) production by LPS-stimulated RAW 264.7 cells in the presence of different extracts of commercial and wild Fucus vesiculosus 1. 1 Mean ± SD of at least two independent assays. DE, dry extract. 3. Discussion 3.1. Chemical Composition In order to establish a relationship between the chemical composition and the biological activities, the phytochemical profiles of the samples were established. F. vesiculosus extracts were characterized according to their main components (pigments, total phenolic content, and phlorotannins) that resulted from different extractions with solvents of different polarities. The chemical composition showed that wild extracts are richer in both carotenoids and chlorophylls. This can be explained, at least in part, by the sample processing methods; for instance, while the wild samples we explored were lyophilized, commercial samples are normally subjected to less conservative methods and long exposure to oxygen and UV radiation during the drying process, which can contribute to the oxidative degradation of some bioactive metabolites [34]. This can be supported by the absence of chlorophyll-a in the commercial sample, which presents higher amounts of chlorophyll derivatives and pheophytin-a, a metabolite resulting from the degradation of chlorophyll (Table 1). Additionally, the time that elapsed between the collection, drying, and analysis of the commercial samples could also affect their chemical profile. Among all the pigments, fucoxanthin was one of the most representative and the only identified in all the samples. However, there were no significant differences between the different extraction solvents in commercial samples, and their concentration was much lower compared with the extracts obtained from the wild F. vesiculosus. Comparing our results obtained with wild F. vesiculosus extracts with those of García-Pérez et al. [35] for Fucus spiralis, it can be observed that the fucoxanthin content in the ethanolic extracts is closely comparable, with 2046.61 μg/g DE in F. vesiculosus and 1171.3 μg/g DE in F. spiralis. Regarding chlorophyll-a, it was not detected in the ethanolic extracts of either species, whereas in the acetonic extracts, the quantities were comparable, with 225.71 μg/g DE in F. vesiculosus and 471.5 μg/g DE in F. spiralis. Lastly, β-carotene was not found in any of the extracts from our commercial F. vesiculosus, which aligns with the results for F. spiralis reported by García-Pérez et al., where this pigment was also absent. Our results are in agreement with Chinnadurai et al. [36], supporting that the acetone extracts of F. vesiculosus are dominated by fucoxanthin, which is the pigment responsible for the color of brown algae. Moreover, Silva et al. [37] also highlight the prominence of high concentrations of pheophytin-a, which potentially contributes to the olive-brown tonality of Fucus, and which was, in parallel with fucoxanthin, one of the dominant pigments identified in our extracts. These studies demonstrate that the extraction method, along with solvent concentration, time of extraction, and temperature, significantly influences both the quantity and type of pigments extracted. Phlorotannins are the main phenolic compounds in brown algae. Extracts obtained from the wild F. vesiculosus presented higher TPC values compared to the commercial ones, with acetone 90% extracts presenting the highest values (1903.83 µg/mg DE). Due to their ability to reduce inflammation and act as antioxidants, phenolic compounds are well-known for their beneficial effects on human health [38,39]. In addition, the efficacy of these compounds is also recognized in the cosmetics field for their ability to overcome hyperpigmentation through the inhibition of the melanin-forming enzyme tyrosinase [40]. Moreover, it is well known that F. vesiculosus forms mixed belts in the mid-tide zone and that it has one of the highest phenolic content levels (around 5.80% DW) [41]. Phenolic compounds typically dissolve readily in solvents that are less polar than water, like methanol, ethanol, and acetone, with their aqueous mixtures being most often utilized to extract these chemicals. Many investigations have demonstrated that acetone leads to the highest extraction yields, especially when it comes to phlorotannins [42,43,44,45,46]. Regarding our results in TPhC, the highest values were found for the acetone 90% extract for both commercial and wild F. vesiculosus. This is not in accordance with several authors’ findings, who reported that acetone concentrations between 40 and 80% were more successful in producing brown algal extracts with a high phlorotannin content than either pure acetone or water [42,47,48,49]. In the present work, we demonstrate that acetone 90% is the most effective solvent for polyphenols extraction. 3.2. Biological Activities UV radiation is the main cause of skin photoaging by increasing the production of ROS, which leads to the breakdown of extracellular matrix components, oxidative stress, inflammation, and cell apoptosis [50]. Antioxidants, such as pigments or polyphenols present in algae like Fucus vesiculosus, act as potent antioxidants and UV filters. This is due to their chemical structure, and in particular, the presence of hydroxyl groups, which enhances both UV absorption and antioxidant activity [51]. The extracts obtained from commercial samples revealed weaker activity than the wild ones, which were significantly more effective in reaching lower IC50 values, for the scavenging of the two physiologic free radicals analyzed herein. Regarding the O2•− scavenging assay, our results with the acetone 70% extract of the wild F. vesiculosus showed higher O2•− scavenging activity (IC50 = 0.39 mg DE/mL) than the wild Fucus spiralis acetone 70% reported by Ferreres et al. [52] (IC50 = 1.30 mg DE/mL). The antioxidant potential observed in our extracts may be attributed to their richness in carotenoids (7082.05 µg/g DE) and polyphenols (1042.75 µg/mg DE), specifically fucoxanthin (7067.12 µg/g DE) and phlorotannins (2.89 µg/mg DE), respectively. In fact, our results agree with those reported by Zaragozá et al. [53], who obtained a negative correlation between TPC and O2•− scavenging activity for F. vesiculosus extracts. These authors reported a TPC of 163,000 µg/mg DE and O2•− scavenging activity of 0.694 mg DE/mL for their ethanolic extract (50–70% ethanol) with fucoxanthin content measured at 1240 µg/g DE. This indicates that while our wild ethanolic extract has lower TPC, it exhibits a higher fucoxanthin concentration and enhanced O2•− scavenging ability. Additionally, the negative correlation observed by Lee et al. [54] and Nakai et al. [55] in brown algae further supports the relationship between O2•− scavenging and fucoxanthin. This can be corroborated by Miyashita et al. [56], who noted that fucoxanthin has a strong ability to scavenge a variety of free radicals and quench singlet oxygen, suggesting that the higher fucoxanthin content in our extracts may contribute to their improved antioxidant activity. Moreover, fucoxanthin has been shown to have antioxidant, anti-inflammatory, anti-cancer, anti-obesity, anti-diabetic, and hepatoprotective effects [57], which implies that extracts with a high concentration of fucoxanthin have a high potential not only for their application in skincare but also for the treatment of multiple diseases. In •NO scavenging activity, acetone 90% extracts were the most effective, closely followed by acetone 70% extracts, with ethanolic extracts presenting the weakest activity. These findings suggest that the polarity of the solvent plays an important role in the extraction of bioactive compounds, with the less polar being the most active. This is in agreement with other authors who affirmed that the type of solvent employed in the extraction strongly influences the antioxidant activity, since compounds of different polarities are extracted, leading to different levels of antioxidant potential [58]. Beyond phenolic compounds and based on chemical characterization, fucoxanthin and pheophytin-a may significantly contribute to this scavenging activity, taking into account that acetone 90% extracts are considerably richer in pheophytin-a and fucoxanthin compared to the other extracts. Consequently, the combined presence of these compounds in the acetone 90% extracts may enhance their •NO scavenging capacity beyond that of phenols alone. Previous studies have demonstrated the radical scavenging potential of fucoxanthin and pheophytin-a [59,60,61,62]. It seems that TPC and phlorotannins play an important role in •NO scavenging activity, which is in accordance with different authors [31,63,64,65,66,67] who support the direct relationship between the TPC and antioxidant activity of F. vesiculosus extracts. However, these are not the only compounds responsible for •NO scavenging. Previous studies revealed the strong influence of pigments such as chlorophylls and carotenoids as antioxidant components [68,69,70,71], and our extracts are particularly rich in fucoxanthin and pheophytin-a, a chlorophyll-a derivative. In fact, chlorophylls (p < 0.01) and carotenoids (p < 0.05) also play an important role in this biological activity. Specifically, fucoxanthin, chlorophyll-a, phaeophytin-a, and β-carotene presented a negative correlation with •NO scavenging IC50. These results are particularly interesting and show the potential of these dry extracts to be used in cosmetics as well as in the treatment of diseases resulting from oxidative stress. This includes diseases associated with inflammation triggered by oxidative stress, which is the cause of many chronic diseases [72]. The primary cause of photoaging is the direct exposure of skin to UV radiation, which lowers the levels of ECM elements such as HA [73]. As these elements are necessary to keep the skin healthy, inhibiting the enzymes that break them down—like collagenase, elastase, and hyaluronidase—constitutes a good approach to slow down the skin aging process. Furthermore, it is crucial to inhibit tyrosinase, an enzyme responsible for melanin production, which is overexpressed with UV radiation, in order to stop excessive pigmentation that is not desired [74]. In the tyrosinase assay, wild F. vesiculosus presented higher inhibitory potential compared with the commercial one, with acetone 90% being the best extraction solvent. The different activity in the samples was compared with kojic acid (IC50 4.09 ± 0.47 µg/mL), showing that acetone 90% extract of the wild sample was significantly more effective, presenting an IC50 value three times lower than the reference drug (IC50 1.23 ± 0.3 µg DE/mL). In addition, TPC and phlorotannins were highlighted for playing an important role in tyrosinase inhibition. The previous affirmation is supported by several authors who also demonstrated the strong potential linked with the high phenolic compounds (phlorotannins) known for their strong photoprotective, anti-enzymatic, and antioxidant potential [25,26,75,76,77]. In support of this, acetone 70% extracts of F. vesiculosus and F. spiralis reported by Barbosa et al. [78] have shown tyrosinase IC50 values of 2546.82 and 861.73 μg DE/mL, respectively (p < 0.0001), with phlorotannin concentrations of 355.80 and 364.07 μg of phloroglucinol equivalents (PhEq)/mg DE, respectively. In comparison, our results indicate significantly stronger inhibition in acetone 70% extracts of commercial and wild F. vesiculosus, with IC50 values of 8.96 and 2.71 μg DE/mL, respectively. However, the phlorotannin levels in the commercial and wild extracts were notably lower, at 3.02 and 2.89 μg PhEq/mg DE, respectively. Moreover, another study reported that an ethanolic extract of F. vesiculosus exhibited a similar tyrosinase inhibition value (IC50 = 15.3 µg DE/mL) to our commercial ethanol 60% extract (IC50 14.76 µg DE/mL) [79]. Also, there are different studies of brown algal extracts that are as effective as kojic acid [80,81,82]. In this context, Grina et al. [83] reported an ethanol 70% extract of F. spiralis showed a phenolic content of 22.9 µg/mg DE, with a remarkable IC50 value for tyrosinase inhibition of 6.19 µg DE/mL. Conversely, in our study, the phenolic content of wild F. vesiculosus ethanol 60% extracts showed significantly higher at 792.28 µg/mg DE, yielding an even lower IC50 of 3.64 µg DE/mL. These results further underscore the potential of wild F. vesiculosus, exhibiting notably superior inhibitory activity compared to both F. spiralis and commercial F. vesiculosus. Furthermore, based on these two studies, fucoxanthin may play a significant role in tyrosinase inhibition. In vivo studies conducted by Thomas and Kim [84] demonstrated that fucoxanthin isolated from Laminaria japonica suppressed tyrosinase activity in ultraviolet B (UV-B)-irradiated guinea pigs and inhibited melanogenesis in UV-B-irradiated mice. Similarly, Shimoda et al. [85] reported that fucoxanthin reduced tyrosinase activity, melanogenesis in melanoma cells, and UVB-induced pigmentation. As for tyrosinase, wild F. vesiculosus exhibited the highest HAase inhibition, with the acetone 90% extract with the lowest IC50 value of 0.05 mg DE/mL, followed by the acetone 70% extract with an IC50 of 0.16 mg DE/mL. Comparing our findings with existing F. vesiculosus studies, the available data are limited. Notably, Pozharitskaya et al. [28] reported that high molecular weight fucoidan isolated from F. vesiculosus exhibited a concentration-dependent HAase inhibition with an IC50 of 2.9 mg DE/mL. Although this IC50 value indicates a lower inhibitory capacity compared to our acetone extracts, it underscores the potential of F. vesiculosus components in HAase inhibition. Furthermore, while there are no direct comparisons available with other F. vesiculosus studies regarding HAase inhibition, we can refer to the findings of Ferreres et al. [52], who investigated acetone 70% extracts of Fucus spiralis. Although F. vesiculosus demonstrated lower IC50 values, indicating a superior capacity to inhibit Haase, it is crucial to acknowledge the differences between these species. Therefore, our results emphasize the promising potential of F. vesiculosus extracts in Haase inhibition while also highlighting the need for further studies focused specifically on this species. There is a relationship between TPC (r = −0.837), phlorotannins (r = −0.768), and Haase inhibition (p < 0.01) which is in agreement with previous reports of brown algae extracts [74,86]. In fact, the better results obtained with wild F. vesiculosus are the ones that have the highest TPC, and also phlorotannins as a consequence, considering that these compounds have already been demonstrated to exhibit strong antioxidant and photoprotective potential, as well as the ability to inhibit specific enzymes involved in the skin aging process [25,26,75,76,77]. After stimulation with LPS, RAW 264.7 cells pre-treated with serial dilutions of acetonic and ethanolic F. vesiculosus extracts exhibited a marked decrease in •NO without presenting cytotoxic effects. There were no significant differences between both groups of samples (commercial vs. wild); however, differences were observed between the different extraction solvents. It is remarkable that the higher the pigment and phenolic content, the higher the anti-inflammatory potential of the extracts, which led to lower IC25 values for the acetone 90% extracts, followed by acetone 70% and ethanol 60%. Additionally, previous studies have shown that the production of inflammatory mediators by macrophages stimulated with LPS can be attenuated by carotenoids [87,88]. Supporting this, Heo et al. [87,89] used fucoxanthin on RAW 264.7 cells stimulated by LPS and found that the expression levels of •NO, TNF-α, and IL-6 were significantly inhibited. This suggests that fucoxanthin may alleviate inflammatory diseases and modulate macrophage activation. The mechanism by which fucoxanthin inhibits •NO production appears to be related to the down-regulation of mRNA and protein expression of the inducible nitric oxide synthase (iNOS), as well as the down-regulation of TNF-α and IL-6 gene expression. Lin et al. [90] demonstrated that pheophytin-a can suppress •NO production in LPS-stimulated RAW 264.7 cells, potentially through dual mechanisms involving the inhibition of NOS2 promoter activities and modulation of the ERK and STAT-1 pathways. Although a significant correlation with pheophytin-a was not found, a negative correlation (p < 0.01) was observed between various chlorophyll derivatives and the anti-inflammatory capacity of the extracts in LPS-stimulated RAW 264.7 cells. This suggests that similar mechanisms may underlie the anti-inflammatory effects observed in this study. Our results are in accordance with those reported by Barbosa et al. [91], who explored purified phlorotannin extracts from cultivated and wild F. vesiculosus, harvested on the north coast of Portugal, which achieved only 25% of inhibition of •NO production by LPS-exposed macrophages at 317 µg DE/mL and 56.5 µg DE/mL, respectively. In the same study, other Fucus species were analyzed, showing similar IC25 values. Fucus guirii G.I. Zardi, K.R. Nicastro, E.S. Serrão and G.A. Pearson, F.spiralis, and F. serratus showed IC25 values of 97.7 µg DE/mL, 95.9 µg/mL, and 77.00 µg DE/mL, respectively, not achieving the 50% of inhibition until the highest concentration tested (500 µg DE/mL). However, Zaragozá et al. [53] reported higher inhibition rates for F. vesiculosus (30–35% and 50–70% ethanol) extracts than the ones shown in this study, reaching IC50 values in both ethanolic extracts of 95 µg DE/mL and more than 100 µg DE/mL, respectively. Only a few studies have examined the anti-inflammatory activity of Fucales phlorotannin extracts [92,93,94,95]. Moreover, the currently available work on phlorotannin extracts from F. vesiculosus has solely examined how LPS and/or PMA-stimulated macrophages block the release of •NO [53,91,96]. Our results can be explained by the ones reported by Barbosa et al. [91], where samples with equal phlorotannin contents induced a different effect on •NO production and samples with extremely different phlorotannin content demonstrated identical inhibitory capacities. Catarino et al. [97] also showed evidence that the qualitative composition and the complexity of these compounds in the extracts could determine the production of •NO in RAW 264.7 exposed to LPS and, consequently, their anti-inflammatory activity. Further research should focus on optimizing extraction protocols to enhance the yield and bioactivity of Fucus vesiculosus extracts, including the exploration of green solvents and sustainable methods. In vivo studies would be advantageous to validate the antioxidant, anti-inflammatory, and anti-aging effects observed in vitro, with particular attention to safety and efficacy in clinical settings. Additionally, investigating the bioavailability and stability of the bioactive compounds will be crucial for product development. Elucidating the mechanisms of action behind the biological effects of the extracts, through molecular pathway analysis, could deepen our understanding of their therapeutic potential. The impact of environmental factors, geographic location, and harvesting conditions on the chemical composition of F. vesiculosus should also be examined to explain the differences between wild and commercial samples. Comparative studies with other marine species may identify alternative sources of bioactive compounds. Finally, developing stable and effective formulations that incorporate F. vesiculosus extracts, followed by efficacy testing in real-world applications, will be key to translating these findings into cosmetic and pharmaceutical products. 4. Materials and Methods 4.1. Sample Collection and Pre-Treatment The commercial samples of the brown seaweed F. vesiculosus were purchased from MORAIS e COSTA & CA. LDA. (Lot: 1011.199.22) and collected on France’s Atlantic coastline, while the wild samples were collected at Praia Norte (41.6970° N, 8.8510° W, Viana do Castelo, Portugal) in February 2024. After collection, fresh seaweeds were cleaned of debris and epiphytes, frozen at −20 °C, and freeze-dried (LyoQuest Plus ECO, Telstar, Barcelona, Spain). Afterward, both algae (commercial and wild) were triturated until we obtained a homogeneous powder. Upon completion of this process, the algae samples were stored in a desiccator until further extraction. 4.2. Preparation of Seaweed Extracts Subsequently, the samples were extracted in duplicate with three different solvents (acetone 90%, acetone 70%, and ethanol 60%). The extractions were performed by adding 6 g of dried seaweed into 30 mL of solvent in each extraction for 1 h at room temperature and with agitation (350 rpm, with a magnetic stirrer Velp AREC). For the preparation of the extracts, an analytical balance (Sartorius Quintix®, Göttingen, Germany) with a range between 0.0001 g and 210 g was used for weighting samples. Samples were then centrifuged (3000 rpm, 2 min, 25 °C) (Thermo ScientificTM HERAUS MegafugeTM 16R, Waltham, MA, USA), and the supernatant was filtered with a 0.22 µm pore membrane and evaporated under reduced pressure (BUCHI R-210 Rotary Evaporator, Cambridge, MA, USA). The resulting DE was kept at −20 °C until further chemical and biological analysis. 4.3. Phytochemical Characterization 4.3.1. Determination of Pigments Profile by HPLC-PDA Extracts were resuspended in the same extraction solvent (HPLC-grade) to a final concentration of 25 mg/mL for extracts obtained from wild samples and 50 mg/mL for extracts obtained from commercial samples, and filtered through a 0.22 µm pore membrane before injection. Carotenoid analysis was conducted using a Waters Alliance 2695 high-performance liquid chromatography (HPLC) system with a photodiode array detector (PDA) (USA) for resolution, detection, and identification of the compounds of interest. The stationary phase was a YMC Carotenoid C30 (250 × 4.6 mm; 5 μm) column, kept at a constant temperature (25 °C) with a column heater (Waters Corporation, Milford, CT, USA). The mobile phase consisted of two solvents: methanol (A) and tert-butyl methyl ether (B) (VWR Prolabo), starting with 95% A and initiating a gradient to achieve 10% B at 4 min, 18% B at 19 min, 30% B at 21 min, 50% B from 23 to 29 min, 80% B from 30 to 34 min, and 5% B from 35 to 37 min. The flow rate was 0.90 mL/min, and the injection volume was 10 µL. Data were processed using Empower2 chromatography software (Waters, USA). Spectral data from all peaks were collected in the range of 200 to 750 nm. Compounds were identified by comparing their retention times and UV-Vis spectra with those of authentic standard solutions. Carotenoid quantification was achieved by measuring the absorbance recorded in the chromatograms relative to external standards at 450 nm. Fucoxanthin, violaxanthin, chlorophyll-a, zeaxanthin, and β-carotene were quantified using authentic standards solutions (Extrasynthese, Genay, France; Sigma-Aldrich, St. Louise, MO, USA; DHI, Horsholm, Denmark). Unidentified xanthophylls were quantified using the calibration curve of fucoxanthin, β-carotene derivatives using the calibration curve of β-carotene, and chlorophyll derivatives and pheophytin-a using the calibration curve of chlorophyll-a. Calibration curves were established with five different concentrations of standards, chosen to represent the range of compound concentrations in the samples. The calibration plots and r2 values for the analyzed carotenoids and chlorophyll-a are presented in Table 6. Table 6Calibration curves of authentic standards used for quantification of different carotenoids and chlorophylls.StandardsCalibration Curve r 2 Fucoxanthiny = 108029.9x − 4009.90.9994Violaxanthiny = 100034412.5x + 83925.90.9999Zeaxanthiny = 273673431.2x + 188440.90.9895β-Caroteney = 75843350.4x + 2360.10.9996Chlorophyll-ay = 12850733.8x − 6082.00.9943 Calibration curves of authentic standards used for quantification of different carotenoids and chlorophylls. 4.3.2. Polyphenols Quantification The total phenolic content (TPC) of F. vesiculosus extracts was measured according to the colorimetric assay of Folin–Ciocalteu (Folin and Ciocalteu, 1927), with some modifications previously reported [98]. A standard curve (1) was built using six different concentrations of phloroglucinol (0.015 to 0.5 mg/mL), and the total phenols in each extract were expressed in µg of PhEq per mg of DE, with two independent assays carried out in duplicate. The phlorotannins content of F. vesiculosus extracts was measured according to the 2,4-dimethoxybenzaldehyde (DMBA) assay proposed by (Stern et al., 1996) with some modifications [96]. The absorbance of the sample was determined after 60 min of incubation in the dark at room temperature at 515 nm, using a Synergy HT Multi-detection microplate reader operated by GEN5TM software (Gen5 version, Agilent BioTek, Santa Clara, CA, USA). A standard curve (2) was obtained using seven different concentrations of phloroglucinol (0.003 to 0.25 mg/mL). Phlorotannins were expressed in µg of PhEq per mg of DE. Two independent assays were carried out in triplicate. 4.4. Antioxidant Capacity 4.4.1. •NO Scavenging Nitric oxide radical (•NO) scavenging was measured following the methodology described by Lopes [99] with some modifications. The procedure is based on the determination of the amount of nitrite accumulated in the wells containing extract dilutions after 60 min of incubation. Based on the Griess reaction, equivalent volumes (75 µL) of the incubated mixture and Griess reagent [1:1 mixture (v/v) of 1% sulfanilamide and 0.1% N-(1-naphthyl) ethylenediamine in 2% H3PO4] were combined and incubated for 10 min at room temperature in the dark. At 562 nm, the absorbance was measured using a 96-well plate in a Synergy HT Multi-detection microplate reader operated by GEN5TM software. The results were expressed in the percentage of radical scavenging relative control. The results for the calculated IC50 values were expressed as the mean ± SD (µg/mL) of at least four independent assays performed in duplicate. The IC50 values and corresponding dose–response curves were calculated with Graphpad Prism® software (San Diego, CA, USA; version 8.0.2, for Windows). 4.4.2. Superoxide Anion Radical (O2•−) Scavenging Superoxide Anion Radical (O2•−) scavenging was measured following the methodology described by Lopes [99] with some modifications. All the reagents were dissolved in phosphate buffer (19 µM, pH 7.4). A volume of 50 µL of each extract dilution was mixed with the same volume of NADH solution (166 µM) and 150 µL of NBT (43 µM) in a 96-well plate. After the addition of 50 µL of PMS (2.7 µM), the rate of reaction was monitored with a Synergy HT Multi-detection microplate reader operated by GEN5TM software. The extracts’ scavenging capability was measured by tracking how it influences the reduction of NBT caused by O2•− for two minutes, at 562 nm, at RT. The results were expressed in the percentage of radical scavenging relative control. The results for the calculated IC50 values were expressed as the mean ± SD (mg/mL) of at least four independent assays performed in duplicate. The IC50 values and corresponding dose–response curves were calculated with Graphpad Prism® software. 4.5. Enzymatic Assays 4.5.1. Tyrosinase Inhibition The tyrosinase inhibition assay was performed according to [100] with some modifications. In a 96-well plate, 10 µL of extract serial dilutions were mixed with 90 µL of phosphate buffer (50 mM, pH 6.5) and 50 µL of tyrosinase (50 U/mL in phosphate buffer). Serial dilutions were prepared in DMSO, negative controls were prepared in the absence of extracts, and a positive control was prepared with Kojic acid. The mixture was incubated for 20 min at room temperature. After, 50 µL of L-DOPA (L-3,4-dihydroxyphenylalanine) solution (2.5 mM in phosphate buffer) was added, and the rate of reaction was measured with a Synergy HT Multi-detection microplate reader operated by GEN5TM software, in kinetic mode, at 475 nm. The results for the percentage of tyrosinase inhibition in the presence of F. vesiculosus extracts were compared with the untreated control. The results for the calculated IC50 values were expressed as the mean ± SD (µg/mL) of at least four independent assays performed in duplicate, and the corresponding dose–response curves were calculated with Graphpad Prism® software. 4.5.2. HAase Inhibition The hyaluronidase inhibition assay followed the method proposed by [52] with slight modifications. A total of 25 µL of each extract serial dilution was mixed with 175 µL of hyaluronic acid (HA) (0.7 mg/mL) and 25 µL of hyaluronidase (HAase) (900 U/mL in NaCl 0.9%). All the extract serial dilutions were prepared in HCOONa buffer (0.2 M, pH 3.68). After 30 min of incubation at 37 °C, the enzymatic reaction was stopped by adding 25 µL of disodium tetraborate (0.8 M prepared in water: buffer, 5:2 v/v) solution and heated for 3 min in a water bath at 95 °C. The reaction tubes were cooled down at room temperature before adding 375 µL of DMAB [4-(Dimethylamino) benzaldehyde] 0.67 M (10%) solution. After 20 min of incubation at 37 °C with DMAB, the absorbance of the colored product was measured at 560 nm in a Synergy HT Multi-detection microplate reader operated via GEN5TM software. The negative control was measured in the absence of extract. The results were expressed in the percentage of enzyme inhibition in comparison to the untreated control. The results for the calculated IC50 values were expressed as the mean ± SD (mg/mL) of at least three independent assays performed in triplicate, and the corresponding dose–response curves were calculated with Graphpad Prism®. Disodium cromoglycate (DSGC) [101] was used as a positive control. 4.6. Anti-Inflammatory Potential 4.6.1. Cell Culture and Maintenance To assess the cytotoxicity and measure the •NO released by RAW 264.7 cells treated with F. vesiculosus extracts, an in vitro cytotoxicity assay was performed using this cell line of mouse macrophages (provided by ATCC®). Cells were cultured in DMEM Glutamax medium (Dulbecco’s Modified Eagle Medium DMEM GlutaMAXTM-Gibco, Glasgow, UK), supplemented with 10% (v/v) of fetal bovine serum (Biochrom, Berlin, Germany), 0.1% of amphotericin B (GE Healthcare, Little Chafont, UK), and 1% penicillin–streptomycin (Pen-Strep 100 IU/mL and 10 mg/mL, respectively) (Gibco, Berlin, Germany). Cell maintenance and assays were performed at 37 °C in a 5% CO2 humidified atmosphere, and the culture medium was renewed every two days. At 80–90% confluence, cells were detached using a cell scraper to proceed with their seeding or transference. The assays were performed with cell passages between 17 and 20. 4.6.2. Cell Viability—MTT Assay The MTT assay, previously described in Barbosa et al. [91] with slight modifications, was chosen to assess RAW 246.7 cell viability. Macrophages were seeded in 96-well plates (3.5 × 104 cells/well). Following a 24 h adhesion time, the culture media was removed, and the cells were pre-exposed during 2 h to 100 µL of fresh medium containing the extracts at five different serial doses, ranging from 12.5 to 200 µg/mL. All the extracts were prepared in dimethyl sulfoxide (DMSO, Gibco) and diluted with DMEM prior to cell exposure. The highest concentration of DMSO was not more than 1%, in order to not affect cell viability. After 2 h of pre-incubation with the extracts, cells elicited with LPS were added (final LPS concentration of 1 µg/mL). Then, the cells were maintained under the same conditions for 22 h more. After the incubation period, 75 µL of the cell’s supernatant was transferred to a new 96-well plate in order to determine •NO release and the leftovers of the medium were vacuumed. The cell viability was measured in the original seeded plate by adding 100 µL of MTT solution (0.5 mg/mL in DMEM) following a further incubation of 45 min at 37 °C. The MTT solution was vacuumed, and the formazan salts were dissolved with 100 µL of DMSO. The absorbance of the solubilized formazan salts was quantified spectrophotometrically at 515 nm using a Synergy HT Multi-Detection microplate reader operated via GEN5TM software. Cytotoxicity was expressed as the percentage of cell viability relative to the untreated control. 4.6.3. •NO Release by RAW 264.7 Cells The accumulated nitrite (NO2−) in the extracellular media was determined as a measure of •NO generation, as per a previously described technique [91]. As previously mentioned, after 24 h of incubation, 75 µL of culture media were transferred to a new 96-well plate. For measuring the •NO release, 75 µL of Griess reagent was added to the cell’s supernatant and incubated for 10 min at RT in the absence of light. The absorbance of the formed chromophore was read at 562 nm using a Synergy HT Multi-Detection microplate reader operated via GEN5TM software. To deduce the effect of the extracts in the basal •NO generation, and discard a potential pro-inflammatory activity, the production of •NO by RAW 264.7 cells was also evaluated in the presence of the extracts without LPS stimulation. 4.7. Statistical Analysis The statistical analysis was performed using IBM SPSS STATISTICS software, version 27.01.0, IBM Corporation, New York, NY, USA (2020). Data were analyzed for normality and homogeneity of variances using Kolmogorov–Smirnov and Leven’s tests, and then submitted to one-way ANOVA using a Tukey’s HSD (honest significant difference) as a post hoc test, or to a t-test. A Pearson correlation test was used to compare normalized expression data between the chemical profile and the biological activities of both wild and commercial F. vesiculosus. The results for the calculated IC50 and IC25 values were expressed as means ± SD (mg/mL or µg/mL) of at least four independent assays, performed in duplicate, for free radicals and enzymatic analysis, and at least three independent assays performed in duplicate, for cell analysis. 5. Conclusions This study highlights the significant influence of the origin of natural samples, as well as the selection of solvents, on the extraction efficiency and bioactivity of Fucus vesiculosus. Extracts obtained from wild samples showed superior antioxidant potential compared to commercial ones. Regarding solvent selection, acetone 90% was revealed to be the most effective, resulting in the lowest IC50 values for O2•− and •NO scavenging activities, emphasizing its efficacy. Phytochemical analysis revealed significant differences in the content of polyphenols, phlorotannins, and pigments between wild and commercial F. vesiculosus samples, with wild extracts showing higher levels. Wild samples, particularly those extracted with 90% acetone, exhibited superior antioxidant and anti-inflammatory activities, as well as enzyme inhibition (tyrosinase and hyaluronidase), relevant to anti-aging properties. These findings suggest that wild F. vesiculosus has greater potential for cosmetic applications due to its higher content of bioactive compounds and enhanced biological activities compared to commercial samples. Furthermore, the harvesting of this wild species, which is authorized and controlled by competent authorities and subject to rigorous quality control, makes it a valuable resource in the area of biotechnology. Acknowledgments Graciliana Lopes thanks the FCT for financial support through the Scientific Employment Stimulus—Individual Call (https://doi.org/10.54499/2021.01768.CEECIND/CP1665/CT0007). The authors would like to thank the EU-CONEXUS Alliance and its Joint Master Programme in Marine Biotechnology for the research exchange that allowed the realization of this work. Author Contributions Conceptualization, G.L. and C.P.-S.; methodology, M.M.-Q.; formal analysis, M.M.-Q., G.L. and C.P.-S.; investigation, M.M.-Q.; resources, F.A., M.D., V.V., G.L. and C.P.-S.; writing—original draft preparation, M.M.-Q.; writing—review and editing, G.L., C.P.-S., F.A., M.D. and V.V.; supervision, G.L. and C.P.-S.; project administration, G.L.; funding acquisition, V.V. All authors have read and agreed to the published version of the manuscript. Institutional Review Board Statement Not applicable. Data Availability Statement Data will be made available upon request to the corresponding authors. Conflicts of Interest The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. Funding Statement This research was co-funded by the Portuguese Foundation for Science and Technology (FCT) projects UIDB/04423/2020 and UIDP/04423/2020 of CIIMAR. Footnotes Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. References Associated Data Data Availability Statement Data will be made available upon request to the corresponding authors.